Skip to content

TCM diagnosis and evaluation scheme optimization for acute viral myocarditis

Acute viral myocarditis TCM diagnosis and evaluation scheme optimization

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000298
Enrollment
Unknown
Registered
2009-01-08
Start date
2009-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Viral myocarditis

Interventions

A:Based on the control scheme, TCM syndrome differentiation and treatment
B:Based on the control scheme, yu Dan honor heart pills
C:Conventional routine treatment

Sponsors

The First Hospital, Tianjin University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. With acute viral myocarditis of diagnostic standard; 2. with TCM syndrome differentiation; 3. at the age of 14-40 years old. Informed consent and signed.

Exclusion criteria

Exclusion criteria: 1. merger adams-stokes syndrome, and congestive heart failure with or without myocardial infarction sample ecg changes, cardiac shock, acute renal failure, sustained ventricular tachycardia with hypotension or myocardial pericarditis one or more of such behavior; 2. rheumatoid myocarditis, congenital heart disease, primary cardiomyopathy, toxic myocarditis, connective tissue diseases and metabolic disease myocardial impairment, hyperthyroidism, primary endocardial elastic fiber hyperplasia, congenital atrioventricular block, coronary heart disease, beta receptors, hyperthyroidism, cardiac autonomic nerve function abnormal function; 3. combined liver, kidney, hematopoietic system such as the primary disease; 4. allergic constitution of two above (or drug allergy); 5. In January, almost five clinical trials of patients. 6. pregnancy or lactating women.

Design outcomes

Primary

MeasureTime frame
Disease index;

Secondary

MeasureTime frame
Syndrome indicator;

Countries

China

Contacts

Public ContactJunping Zhang
tjzhtcm@163.com+86 022 27432016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026